Roche Pharmaceuticals A/S
CVR 25230515 · Public limited company (A/S) · Active · Low risk
Roche Pharmaceuticals A/S is a Public limited company (A/S), founded on , based in København V. The company is registered in the industry engroshandel med medicinalvarer og sygeplejeartikler. Our model estimates a bankruptcy risk of 0.0% over the next 12 months, which is 0.0 times the average for Danish companies. 20 annual reports have been published, of which 3 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK 195.2m and a net result of DKK 31.3m.
Bankruptcy risk for Roche Pharmaceuticals A/S
0.0 × the average (1.41%) · higher risk than 0% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 25230515
- Status
- Active
- Company type
- Public limited company (A/S)
- Founded
- (56 years)
- Address
- Flaskehalsen 17, 4.
1799 København V - Municipality
- København
- Industry
- Engroshandel med medicinalvarer og sygeplejeartikler (464610)
Bankruptcies in the industry: Engroshandel med andre maskiner og andet udstyr - Share capital
- DKK 4.0m
- Employees
- 120 (2018)
- Auditor
- KPMG P/S
- Audit opted out
- No
Warning signs
| Annual reports filed late | 4 of 31 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 44.1% |
| Current ratio | 180% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 19 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 7 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | DKK 928.8m | DKK 827.0m | DKK 761.4m |
| Gross profit | DKK 135.3m | DKK 126.7m | DKK 145.1m |
| Net profit | DKK 31.3m | DKK 24.3m | DKK 36.5m |
| Equity | DKK 195.2m | DKK 163.9m | DKK 139.6m |
| Total assets | DKK 442.7m | DKK 355.3m | DKK 357.6m |
| Cash | DKK 0 | DKK 0 | – |
| Short-term debt | DKK 240.4m | DKK 186.2m | – |
| Tax owed | DKK 6.9m | DKK 0 | – |
| Avg. employees | 97 | 96 | – |
Latest annual report: Reporting class C, large enterprise · auditor's statement: Auditor's report on audited financial statements · KPMGStatsautoriseret Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 185 | Late | |
| 1 Jan 2024 – 31 Dec 2024 | 183 | ||
| 1 Jan 2023 – 31 Dec 2023 | 181 | ||
| 1 Jan 2022 – 31 Dec 2022 | 184 | Late | |
| 1 Jan 2021 – 31 Dec 2021 | 181 | ||
| 1 Jan 2020 – 31 Dec 2020 | 180 | ||
| 1 Jan 2019 – 31 Dec 2019 | 244 | Late | |
| 1 Jan 2018 – 31 Dec 2018 | 141 | ||
| 1 Jan 2017 – 31 Dec 2017 | 149 | ||
| 1 Jan 2016 – 31 Dec 2016 | 136 | ||
| 1 Jan 2015 – 31 Dec 2015 | 154 | ||
| 1 Jan 2014 – 31 Dec 2014 | 152 | ||
| 1 Jan 2013 – 31 Dec 2013 | 150 | ||
| 1 Jan 2012 – 31 Dec 2012 | 149 | ||
| 1 Jan 2011 – 31 Dec 2011 | 145 | ||
| 1 Jan 2010 – 31 Dec 2010 | 153 | ||
| 1 Jan 2009 – 31 Dec 2009 | 151 | ||
| 1 Jan 2008 – 31 Dec 2008 | 158 | ||
| 1 Jan 2007 – 31 Dec 2007 | 153 | ||
| 1 Jan 2006 – 31 Dec 2006 | 130 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Walter Alwin Werner | ||
| CEO | Ernst Peter Krebs | ||
| CEO | Jean-Willy Tanner | ||
| CEO | Rudolf Fischer | ||
| CEO | Daniel Patrick O'Day | ||
| CEO | Robin Stephen Turner | ||
| CEO | Janet Friedman Makepeace | ||
| CEO | Janet Friedman Makepeace | ||
| CEO | Luc Jozef Leon Dirckx | ||
| CEO | Ronald Jeyung Park | ||
| CEO | Linda Valentin Vestergaard | ||
| CEO | Richard John Wright | ||
| Board | Ehab Abdelmoneim Youssef Hassan | Current | |
| Board | Isabel Marianne Joerin | Current | |
| Board | Carole Hassoun | Current | |
| Board | Ole Nørregaard | ||
| Board | Ole Brøns | ||
| Board | Walter Alwin Werner | ||
| Board | Ernst Peter Krebs | ||
| Board | Jean-Willy Tanner | ||
| Board | Andreas Friedrich Leuenberger | ||
| Board | Markus Christoph Altwegg | ||
| Board | Armin Maximilian Kessler | ||
| Board | Otto August Meile | ||
| Board | Rudolf Fischer | ||
| Board | William Murray Burns | ||
| Board | Michael Egede Budtz | ||
| Board | Claude Georges Charles Schreiner | ||
| Board | Daniel Patrick O'Day | ||
| Board | Robin Stephen Turner | ||
| Board | Peter Hug | ||
| Board | Luc Jozef Leon Dirckx | ||
| Board | Janet Friedman Makepeace | ||
| Board | Janet Friedman Makepeace | ||
| Board | Jennifer Elizabeth Cook | ||
| Board | Beat Christoph Krähenmann | ||
| Board | Ronald Jeyung Park | ||
| Board | Richard John Wright | ||
| Board | Beat Christoph Krähenmann | ||
| Board | Darine Ghanem | ||
| Board | Maria Falkenberg Petersen | ||
| Owner (100%) | Roche Holding AG | Current | |
| Auditor | KPMG P/S | Current | |
| Auditor | PRICEWATERHOUSECOOPERS SERVICES STATSAUTORISERET REVISIONSAKTIESELSKAB | ||
| Auditor | CJ Partnership I/S | ||
| Auditor | CJ Partnership I/S | ||
| Auditor | EY Godkendt Revisionspartnerselskab |
The CEOs' other companies
Ernst Peter Krebs – 1 other companies
- UNILABS A/S Active
Jean-Willy Tanner – 2 other companies
- SYNTEX DANMARK A/S Opløst
- UNILABS A/S Active
Rudolf Fischer – 1 other companies
- UNILABS A/S Active
Daniel Patrick O'Day – 1 other companies
- ROCHE DIAGNOSTICS A/S Active
Janet Friedman Makepeace – 1 other companies
- ROCHE DIAGNOSTICS A/S Active
Ronald Jeyung Park – 2 other companies
- RICC A/S Active
- ROCHE DIAGNOSTICS A/S Active
Richard John Wright – 2 other companies
- RICC A/S Active
- ROCHE DIAGNOSTICS A/S Active
Address history (1 moves)
| Flaskehalsen 17, 4., 1799 København V | |
| Industriholmen 59, 2650 Hvidovre |
Former names
| Roche Pharmaceuticals A/S | – now |
| ROCHE A/S. MEDICINALVARER & KEMIKALIER | – |
Employees per year
Other companies at the same address
- JWD 2650 ApS Bankrupt
- AK aesthetics A/S Active
- AKADEMIKLINIKEN DANMARK ApS Active
- Gleeds Denmark ApS Active
- OBI ApS Fusioneret
- RICC A/S Active
- ROCHE DIAGNOSTICS A/S Active
Similar companies in København
- ALFASCAN ApS København K
- LUNDBECK PHARMA A/S Valby
- ASTRAZENECA A/S København V
- Sundvik ApS Vanløse
- DEXCOM DENMARK, ApS København Ø
- Nitrilehandsker.dk ApS Valby
- DePuy Synthes (Denmark) ApS København K
- ELSE NORDICS APS København S
- MSD Animal Health A/S København V
- DentFriends ApS København S
- Sanad Health ApS København N
- Venteus Medical Devices (ROW) ApS København Ø
Questions and answers about Roche Pharmaceuticals A/S
Has Roche Pharmaceuticals A/S gone bankrupt?
No, Roche Pharmaceuticals A/S is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Roche Pharmaceuticals A/S?
Our model estimates a bankruptcy risk of 0.0% over the next 12 months (low risk), which is 0.0 times the average for Danish companies.
Who is the auditor of Roche Pharmaceuticals A/S?
Roche Pharmaceuticals A/S most recently used KPMG P/S.
When was Roche Pharmaceuticals A/S founded?
Roche Pharmaceuticals A/S was founded on 21 January 1970.
What is the equity of Roche Pharmaceuticals A/S?
Equity was DKK 195.2m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.